Contattaci Contact Us

12 October 2023 - Day 1

  • Opening remarks:

    Speaker Carmine Cardillo

    Session date 12/10/2023 - 08:50

  • Recent advances in drugs acting on the endothelin system

    Speaker Anthony Davenport

    Session date 12/10/2023 - 09:00

  • Identification of new therapeutic vulnerabilities in cancer exploiting the molecular ET-averse

    Speaker Anna Bagnato

    Session date 12/10/2023 - 09:30

  • Discussion 1

    Speaker -

    Session date 12/10/2023 - 09:40

  • The intersection of the endothelin-1 receptor axis with mechanical cues affects PARP inhibitor response in highgrade serous ovarian cancer

    Speaker Giuliano Tocci

    Session date 12/10/2023 - 09:50

  • Discussion 2

    Speaker -

    Session date 12/10/2023 - 10:00

  • Regulation of invasion and peritoneal dissemination of serous ovarian cancer by Endothelin A receptor and Integrin ꞵ interplay

    Speaker I. Masi

    Session date 12/10/2023 - 10:15

  • Discussion 3

    Speaker -

    Session date 12/10/2023 - 10:30

  • Preclinical immunotherapeutic approaches to treat tumours overexpressing endothelin receptors

    Speaker D. Boquet

    Session date 12/10/2023 - 10:35

  • Discussion 4

    Speaker -

    Session date 12/10/2023 - 10:45

  • The endothelin-1/ miR-200b-c/ZEB1 circuit drives novel gasdermin E nuclear functions to fuel inflammatory responses and metastatic progression in high-grade serous ovarian

    Speaker R. Sestito

    Session date 12/10/2023 - 10:50

  • Discussion 5

    Speaker -

    Session date 12/10/2023 - 11:30

  • KeyNote Lecture: Non-selective endothelin receptor antagonism in resistant hypertension: the PRECISION trial

    Speaker Ernesto Schiffrin

    Session date 12/10/2023 - 11:40

  • Discussion 6

    Speaker -

    Session date 12/10/2023 - 11:50

  • Evidence for endothelin regulation of the suprachiasmatic nucleus – the master circadian clock

    Speaker David M. Pollock

    Session date 12/10/2023 - 12:00

  • Discussion 7

    Speaker -

    Session date 12/10/2023 - 12:15

  • Hypertension Worsens Endothelin-1-Mediated Vasoconstrictor Tone in Adults with Obesity

    Speaker Colin Berry

    Session date 12/10/2023 - 12:20

  • Discussion 8

    Speaker -

    Session date 12/10/2023 - 12:30

  • Environmental Enrichment after Ischemic Stroke Decreases Brain Endothelin -1 (ET-1) and ETA Receptor Expression in Spontaneously Hypertensive Rats

    Speaker Y. Abdul

    Session date 12/10/2023 - 12:35

  • Discussion 9

    Speaker -

    Session date 12/10/2023 - 12:45

  • KeyNote Lecture: Effects of endothelin on the brain microvasculature

    Speaker Adviye Ergul

    Session date 12/10/2023 - 15:15

  • Discussion 10

    Speaker -

    Session date 12/10/2023 - 15:30

  • Sovateltide, a neural progenitor cell therapeutic for the treatment of acute ischemic stroke, shows no effect on the thrombolytic activity of t-PA

    Speaker M. Lavhale

    Session date 12/10/2023 - 15:45

  • Discussion 11

    Speaker -

    Session date 12/10/2023 - 16:00

  • Role of Sovateltide Mediated Agonism of Endothelin B Receptors in Regeneration and Repair in the Adult Brain after Ischemic Stroke

    Speaker A. Ranjan

    Session date 12/10/2023 - 16:05

  • Discussion 12

    Speaker -

    Session date 12/10/2023 - 16:10

  • Intranasal inhibition of brain endothelin receptor A (ETA) exerts positive effects on cognitive functions in a hypoperfusion model of VCID in diabetic rats

    Speaker Y. Abdul

    Session date 12/10/2023 - 16:15

  • Discussion 13

    Speaker -

    Session date 12/10/2023 - 16:30

  • Invited Lecture: Advances in the treatment of neurologic disorders using drugs active on the endothelin system

    Speaker Anil Gulati

    Session date 12/10/2023 - 16:40

  • Discussion 14

    Speaker -

    Session date 12/10/2023 - 17:00

13 October 2023 - Day 2

  • Review of recent clinical trials with drugs targeting the endothelin system

    Speaker H. Lambers Heerspink

    Session date 13/10/2023 - 09:00

  • First-line treatment with sparsentan, a dual endothelin and angiotensin receptor antagonist, in patients with immunoglobulin A nephropathy: initial results of the SPARTAN study

    Speaker M. Sayer

    Session date 13/10/2023 - 09:30

  • Discussion 15

    Speaker -

    Session date 13/10/2023 - 09:40

  • Endothelium-derived endothelin-1 mediates sickle cell inflammation and nephropathy

    Speaker Jennifer Pollock

    Session date 13/10/2023 - 09:45

  • Discussion 16

    Speaker -

    Session date 13/10/2023 - 09:55

  • Endothelin A receptor antagonist promotes iron recycling in murine models of iron overload

    Speaker M. Kasztan

    Session date 13/10/2023 - 10:00

  • Discussion 17

    Speaker -

    Session date 13/10/2023 - 10:10

  • Invited Lecture: Is there a role of endothelin targeting for nephroprotection in the era of SGLT2 or mineralcorticoid receptor inhibition?

    Speaker Pierre-Louis Tharaux

    Session date 13/10/2023 - 10:15

  • Discussion 18

    Speaker -

    Session date 13/10/2023 - 10:40

  • KeyNote Lecture: Could targeting the endothelin system become a suitable approach in HFpEF?

    Speaker Kieran Docherty

    Session date 13/10/2023 - 11:05

  • Discussion 19

    Speaker -

    Session date 13/10/2023 - 11:15

  • Endothelin mediates communication between heart and skeletal muscle during heart failure

    Speaker S. Das

    Session date 13/10/2023 - 11:35

  • Discussion 20

    Speaker -

    Session date 13/10/2023 - 11:50

  • Endothelin-1 Impairs the Capacity of Brain Endothelial Cells to Release Tissue-Type Plasminogen Activator

    Speaker A. Berry

    Session date 13/10/2023 - 11:55

  • Discussion 21

    Speaker -

    Session date 13/10/2023 - 12:05

  • Dissecting endothelin-dependent functional responses in human cardiac organoids to identify new heart failure targets

    Speaker S. Foster

    Session date 13/10/2023 - 12:15

  • Endothelin in coronary artery diseases

    Speaker Matthias Barton

    Session date 13/10/2023 - 12:20

  • Discussion 22

    Speaker -

    Session date 13/10/2023 - 12:20

  • Invited Lecture: Endothelin in coronary artery diseases

    Speaker Matthias Barton

    Session date 13/10/2023 - 12:25

  • Hot Topic Presentation: Mandibulofacial dysostosis with alopecia resulting from ETAR gain-of-function

    Speaker Yukiko Kurihara

    Session date 13/10/2023 - 12:30

  • KeyNote Lecture: Role of endothelin in the oxidative stress associated with diabetic vasculopathy

    Speaker Rhian M Touyz

    Session date 13/10/2023 - 12:40

  • Discussion 23

    Speaker -

    Session date 13/10/2023 - 12:50

  • Poster Discussion

    Speaker Ivana Vanĕčková

    Session date 13/10/2023 - 14:00

  • Adipocyte specific ETB receptor knockout attenuates insulin resistance and dyslipidemia in mice fed high fat diet

    Speaker J. Speed

    Session date 13/10/2023 - 15:30

  • Discussion 24

    Speaker -

    Session date 13/10/2023 - 15:40

  • Loss of Endothelin-2 Impairs Early-Stage Adipocyte Differentiation

    Speaker P. Rinastiti

    Session date 13/10/2023 - 15:45

  • Discussion 25

    Speaker -

    Session date 13/10/2023 - 15:55

  • Endothelin-1 promotes perivascular adipose tissue dysfunction in obese mice via Nrf2 downregulation and oxidative stress

    Speaker Rita Tostes

    Session date 13/10/2023 - 16:00

  • Discussion 26

    Speaker -

    Session date 13/10/2023 - 16:10

  • Invited Lecture: Role of endothelin and endothelin antagonism in Non-alcoholic fatty liver disease

    Speaker Wilhelmus Kwanten

    Session date 13/10/2023 - 16:15

  • Discussion 27

    Speaker -

    Session date 13/10/2023 - 16:45

14 October 2023 - Day 3

  • KeyNote Lecture: Update on the use of endothelin antagonists in pulmonary hypertension

    Speaker Noriaki Emoto

    Session date 14/10/2023 - 09:00

  • Discussion 28

    Speaker -

    Session date 14/10/2023 - 09:25

  • Dapagliflozin and ambrisentan co-administration in patients hospitalised with COVID-19. A report from mulTi-Arm therapeutiC sTudy in pre-Icu patients admitted with Covid-19 – Experimental drugs and mechanisms (TACTIC-E)

    Speaker P. Ambery

    Session date 14/10/2023 - 09:30

  • Discussion 29

    Speaker -

    Session date 14/10/2023 - 09:40

  • Acute amelioration of inflammatory activity caused by endothelin-2 deficiency during acute lung injury

    Speaker A. Musthafa

    Session date 14/10/2023 - 09:45

  • Discussion 30

    Speaker -

    Session date 14/10/2023 - 09:55

  • Targeting endothelin signalling for combating SARS-CoV-2-induced osteochondral defect

    Speaker M. T. Au

    Session date 14/10/2023 - 10:00

  • Discussion 31

    Speaker -

    Session date 14/10/2023 - 10:10

  • Invited Lecture: Role of endothelin in vasculitis

    Speaker Neeraj Dhaun

    Session date 14/10/2023 - 10:15

  • Discussion 32

    Speaker -

    Session date 14/10/2023 - 10:45

  • KeyNote Lecture: Endothelin and hair follicle regeneration

    Speaker Michael Rendl

    Session date 14/10/2023 - 11:05

  • Discussion 33

    Speaker -

    Session date 14/10/2023 - 11:30

  • Serum endothelin-1 increased in Indonesian hypertensive females: the result of Sleman HDSS populational survey

    Speaker A. B. Hartopo

    Session date 14/10/2023 - 11:35

  • Discussion 34

    Speaker -

    Session date 14/10/2023 - 11:40

  • Leptin is a novel upregulator of placental endothelin-1 in preeclampsia

    Speaker J. Faulkner

    Session date 14/10/2023 - 11:50

  • Discussion 35

    Speaker Massimo Cardillo

    Session date 14/10/2023 - 12:00

  • Sex-specific role for the clock protein PER1 in the regulation of renal ET-1 in salt-sensitive hypertension

    Speaker Michelle Gumz

    Session date 14/10/2023 - 12:05

  • Discussion 36

    Speaker -

    Session date 14/10/2023 - 12:15

  • Role of endothelin in pre-eclampsia

    Speaker Jan Danser

    Session date 14/10/2023 - 12:20

  • Discussion 37

    Speaker -

    Session date 14/10/2023 - 12:50

  • Highlights of the Meeting

    Speaker Masashi Yanagisawa

    Session date 14/10/2023 - 15:15

  • Closing remarks of the Conference Chairs

    Speaker Carmine Cardillo

    Session date 14/10/2023 - 15:45

VGFM DATA-LAYER

Reserved area

APP FONDAZIONE MENARINI



Pills of Art Menarini

“Pills of Art”
A new multimedia project dedicated to the art world.



New Projects: MINUTI DIGITALE



Minuti Menarini Online

Subscribe for free to the paper version of the magazine



Fondazione Menarini



SIGN UP FOR THE NEWSLETTER

Receive information about the Fondazione Menarini every month.

VGFM DATA-LAYER

Fondazione Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484